06|11|26

Beyond the Molecule: The New Reality of Oncology Commercialization 

As ASCO 2026 made clear, oncology has entered a “post-molecule” era, where clinical efficacy is no longer the primary differentiator, but a baseline expectation. In a new article for PharmaLive, Tim Lewis explores how success now depends on how well therapies integrate into an increasingly complex, overburdened care ecosystem.

06|10|26

A New Blueprint for Brand Campaigns In Pharma Marketing

Pharma marketers can no longer rely on in-market demand alone to drive growth. In a crowded, AI-powered landscape, brands must build connection and familiarity earlier to unlock stronger performance later. This POV reveals the five pillars behind campaigns that drive real ROI.

05|21|26

Pharma’s AI Influencer Future Depends on One Question: Why Would Anyone Care? 

In a new article published on Med Ad News (Pharma Live), Chief Creative Officer Susan Perlbachs explores what recent consumer backlash to AI influencers reveals about the future of influence in healthcare. The takeaway isn’t that audiences reject AI, but that they reject anything that lacks perspective, purpose, or genuine human value.

05|20|26

Google AI Mode & What It Means for Pharma Search

Google’s shift to AI‑generated search is redefining how patients and healthcare professionals discover information. As advertising moves into conversational, intent‑driven experiences, pharma marketers are being pushed to rethink how they show up in moments that increasingly shape decision‑making.

05|15|26

2026 Pharma AI Overviews Report

In the past four years, AI has altered how users and technology discover and engage with information and continues to evolve and reshape the digital landscape. To better understand this transformation, our GEO/SEO team analyzed 10,000 pharmaceutical-specific keywords, uncovering a hidden layer of AI background searches and a rapidly changing landscape where nearly 75% of keywords now trigger AI Overviews and sources shift frequently.

05|11|26

What Adobe Summit 2026 Signals for Pharma Marketing 

Adobe Summit 2026 highlighted a major shift in AI, uncovering new implications for how marketing gets done in pharma.  Our latest POV from our team that attended this year’s summit explores what this shift means and how pharma marketers can start preparing for what’s next. Readers will gain insight into:  Download the POV to learn more.

05|08|26

EVERSANA INTOUCH Names Mike Guarino CEO

EVERSANA INTOUCH has entered a new chapter with the appointment of Mike Guarino as Chief Executive Officer, an industry veteran known for driving growth, innovation and high-performing teams across some of healthcare marketing’s most influential organizations.  

04|29|26

4 Takeaways from Google Cloud’s NEXT 2026 and What’s on the Horizon for Pharma

What does the next chapter of AI‑driven transformation mean for pharma? Faruk Capan, Chief Innovation Officer, recently penned an article for pharmaphorum distilling four key takeaways from Google Cloud’s NEXT 2026 conference, highlighting how the industry is moving beyond experimentation toward accountability, integration, and trust at scale. From connected systems to stronger AI governance, the piece offers timely perspective on what pharma organizations must do next to stay competitive.  

04|22|26

Reimagining Annual Brand Planning With AI

In a recent article for PM360, Chief Strategy Officer John Kenny explores how AI is reshaping the annual brand planning process from a one-time exercise into a more dynamic, insight-driven model that better reflects today’s complex market realities.

04|21|26

Easy Beats Better: Thriving in the New Age of AI-Driven Healthcare

In a healthcare landscape overwhelmed by digital noise and growing complexity, even the strongest brands struggle to stand out and get chosen. In “Easy Beats Better: Thriving in the New Age of AI‑Driven Healthcare”, Tim Lewis, EVP, Strategic Development Oncology & Precision Medicine, John Kenny, Chief Strategy Officer, and Mike Shaffer, VP, Strategic Planner, explore why traditional playbooks are failing and how an AI‑powered, behaviorally grounded approach can help brands cut through “The Great Blur,” reduce friction, and build lasting loyalty.